Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Long-term impact of paediatric critical illness on the difference between epigenetic and chronological age in relation to physical growth.

Tytuł:
Long-term impact of paediatric critical illness on the difference between epigenetic and chronological age in relation to physical growth.
Autorzy:
Verlinden I; Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, B-3000, Leuven, Belgium.
Coppens G; Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, B-3000, Leuven, Belgium.
Vanhorebeek I; Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, B-3000, Leuven, Belgium.
Güiza F; Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, B-3000, Leuven, Belgium.
Derese I; Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, B-3000, Leuven, Belgium.
Wouters PJ; Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, B-3000, Leuven, Belgium.
Joosten KF; Intensive Care Unit, Department of Paediatrics and Paediatric Surgery, Erasmus Medical Centre, Sophia Children's Hospital, Rotterdam, The Netherlands.
Verbruggen SC; Intensive Care Unit, Department of Paediatrics and Paediatric Surgery, Erasmus Medical Centre, Sophia Children's Hospital, Rotterdam, The Netherlands.
Van den Berghe G; Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, B-3000, Leuven, Belgium. .
Źródło:
Clinical epigenetics [Clin Epigenetics] 2023 Jan 14; Vol. 15 (1), pp. 8. Date of Electronic Publication: 2023 Jan 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: Oct./Nov. 2011- : London : BiomedCentral
Original Publication: Berlin : Springer-Verlag
MeSH Terms:
Critical Illness*
DNA Methylation*
Child ; Humans ; Time Factors ; Growth Disorders ; Epigenesis, Genetic ; DNA
References:
Epigenetics. 2022 Nov 16;:1-12. (PMID: 36384393)
Aging (Albany NY). 2020 Nov 9;12(21):21037-21056. (PMID: 33168783)
Nat Rev Genet. 2018 Jun;19(6):371-384. (PMID: 29643443)
Intensive Care Med. 2018 May;44(5):649-651. (PMID: 29063130)
Genome Biol. 2017 Mar 28;18(1):56. (PMID: 28351387)
Stat Med. 1992 Dec;11(16):2093-109. (PMID: 1293671)
Endocr Rev. 2021 Nov 16;42(6):783-814. (PMID: 33788946)
Trials. 2015 May 01;16:202. (PMID: 25927936)
Epigenetics Chromatin. 2013 Mar 03;6(1):4. (PMID: 23452981)
Bioinformatics. 2017 Feb 15;33(4):558-560. (PMID: 28035024)
Genome Biol. 2013;14(10):R115. (PMID: 24138928)
N Engl J Med. 2016 Mar 24;374(12):1111-22. (PMID: 26975590)
Lancet Child Adolesc Health. 2020 Jul;4(7):503-514. (PMID: 32562632)
Handb Clin Neurol. 2014;124:115-26. (PMID: 25248583)
Clin Epigenetics. 2016 Feb 26;8:21. (PMID: 26925173)
Mol Cell. 2013 Jan 24;49(2):359-367. (PMID: 23177740)
Pediatr Crit Care Med. 2018 Mar;19(3):e164-e171. (PMID: 29329164)
Am J Clin Nutr. 2022 Jan 11;115(1):163-170. (PMID: 34134146)
Lancet Respir Med. 2020 Mar;8(3):288-303. (PMID: 32085844)
BMC Bioinformatics. 2017 Feb 13;18(1):105. (PMID: 28193155)
Genome Biol. 2015 Feb 15;16:37. (PMID: 25853392)
BMC Bioinformatics. 2010 Nov 30;11:587. (PMID: 21118553)
Genome Biol. 2015 Jan 30;16:25. (PMID: 25633388)
Genome Res. 2012 Apr;22(4):623-32. (PMID: 22300631)
Aging Cell. 2015 Dec;14(6):924-32. (PMID: 25913071)
Am J Respir Crit Care Med. 2016 Dec 1;194(11):1337-1348. (PMID: 27611700)
Lancet. 2009 Feb 14;373(9663):547-56. (PMID: 19176240)
J Transl Med. 2019 Jan 9;17(1):15. (PMID: 30626398)
Ageing Res Rev. 2018 Dec;48:32-39. (PMID: 30316759)
Cell. 2016 Aug 11;166(4):822-839. (PMID: 27518561)
Clin Nutr. 2006 Feb;25(1):154-62. (PMID: 16297504)
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23329-23335. (PMID: 31611402)
Mol Cell. 2016 Jun 2;62(5):728-44. (PMID: 27259204)
Lancet Respir Med. 2019 Feb;7(2):141-153. (PMID: 30224325)
Chin Med J (Engl). 2021 Sep 14;134(24):2901-2910. (PMID: 34520417)
Clin Nutr. 2021 Mar;40(3):1005-1012. (PMID: 32758384)
Contributed Indexing:
Keywords: Ageing; Children; Critical illness; DNA methylation; Development; Epigenetic; Epigenetic age; Growth; PICU
Molecular Sequence:
ClinicalTrials.gov NCT01536275
Substance Nomenclature:
9007-49-2 (DNA)
Entry Date(s):
Date Created: 20230113 Date Completed: 20230117 Latest Revision: 20230201
Update Code:
20240105
PubMed Central ID:
PMC9840263
DOI:
10.1186/s13148-023-01424-w
PMID:
36639798
Czasopismo naukowe
Background: Altered DNA-methylation affects biological ageing in adults and developmental processes in children. DNA-methylation is altered by environmental factors, trauma and illnesses. We hypothesised that paediatric critical illness, and the nutritional management in the paediatric intensive care unit (PICU), affects DNA-methylation changes that underly the developmental processes of childhood ageing.
Results: We studied the impact of critical illness, and of the early use of parenteral nutrition (early-PN) versus late-PN, on "epigenetic age-deviation" in buccal mucosa of 818 former PICU-patients (406 early-PN, 412 late-PN) who participated in the 2-year follow-up of the multicentre PEPaNIC-RCT (ClinicalTrials.gov-NCT01536275), as compared with 392 matched healthy children, and assessed whether this relates to their impaired growth. The epigenetic age-deviation (difference between PedBE clock-estimated epigenetic age and chronological age) was calculated. Using bootstrapped multivariable linear regression models, we assessed the impact hereon of critical illness, and of early-PN versus late-PN. As compared with healthy children, epigenetic age of patients assessed 2 years after PICU-admission deviated negatively from chronological age (p < 0.05 in 51% of bootstrapped replicates), similarly in early-PN and late-PN groups. Next, we identified vulnerable subgroups for epigenetic age-deviation using interaction analysis. We revealed that DNA-methylation age-deceleration in former PICU-patients was dependent on age at time of illness (p < 0.05 for 83% of bootstrapped replicates), with vulnerability starting from 6 years onwards. Finally, we assessed whether vulnerability to epigenetic age-deviation could be related to impaired growth from PICU-admission to follow-up at 2 and 4 years. Multivariable repeated measures ANOVA showed that former PICU-patients, as compared with healthy children, grew less in height (p = 0.0002) and transiently gained weight (p = 0.0003) over the 4-year time course. Growth in height was more stunted in former PICU-patients aged ≥ 6-years at time of critical illness (p = 0.002) than in the younger patients.
Conclusions: As compared with healthy children, former PICU-patients, in particular those aged ≥ 6-years at time of illness, revealed epigenetic age-deceleration, with a physical correlate revealing stunted growth in height. Whether this vulnerability around the age of 6 years for epigenetic age-deceleration and stunted growth years later relates to altered endocrine pathways activated at the time of adrenarche requires further investigation.
(© 2023. The Author(s).)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies